Purchase Order 36C24925P0523

Award Date 5/6/25
Potential Completion Date 6/30/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mountain Home, TN 37684, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the provision of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. This contract does not utilize a set-aside designation, likely due to the...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is a firm-fixed-price purchase order for the delivery of Novocure's Optune Tumor Treating Fields (TTFields) therapy transducers and related support services. The contract does not utilize any set-aside designations and is part of Novocure's 5-year Federal Supply...
This federal contract award is for the procurement of Novocure's Optune device, a cancer treatment technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract, valued at $49,748.73, was awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), specifically the Veterans Integrated Service Network 12 (VISN 12). The contract is...
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of Optune Transducers, which are part of Novocure's Optune system - an innovative cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract is a firm...
This federal contract award, with a ceiling value of $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the delivery of Optune Plus transducers, which are part of Novocure's proprietary Tumor Treating Fields (TTFields) cancer therapy technology. The contract is a delivery order issued under Novocure's 5-year Federal Supply Schedule (FSS)...
This federal contract award, valued at $12,277.98, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations and is a firm-fixed-price purchase...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. This contract does not utilize any set-aside designations and is being...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, a component of the company's Tumor Treating Fields (TTFields) cancer therapy technology, over a 3-month period. This award is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award, valued at $49,748.73, is for the procurement of Novocure Transducer medical devices by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16), a civilian agency. The contract was awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using Tumor Treating Fields (TTFields) technology. The contract does not utilize any set-aside designations and is a Firm Fixed Price...
This federal contract award, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 (VISN 8) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the procurement of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers in a non-invasive manner. The...

This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the delivery of Optune Plus transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers.

The contract is structured as a firm fixed-price purchase order with a completion date of June 30, 2025. Novocure holds a larger $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which serves as the primary procurement vehicle for the agency to obtain Novocure's Optune line of medical devices and associated support services. This specific contract award does not have a set-aside designation, likely due to the specialized nature of the Optune technology. Novocure acts as the prime contractor, delivering its proprietary cancer treatment devices directly to VA medical centers nationwide without the use of subcontractors.

Generated 5/7/25, 9:46 AM